Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma

Clinical trial NCT07276386 · RECRUITING

Trial details

NCT number: NCT07276386
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Uveal Melanoma

Start date: 2025-12-31
Primary completion: 2030-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.